HLN
Haleon plc NYSE Listed Jul 25, 2022$9.29
+0.60%
vs $9.23
Mkt Cap $41.0B
52w Low $8.65
24.1% of range
52w High $11.28
50d MA $9.20
200d MA $9.70
P/E (TTM)
15.0x
EV/EBITDA
10.1x
P/B
2.5x
Debt/Equity
0.5x
ROE
—
P/FCF
21.2x
RSI (14)
62.20
ATR (14)
$0.14
Beta
0.33
50d MA
$9.20
200d MA
$9.70
Avg Volume
9.5M
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Building 5 · Weybridge, X0 KT13 0NY · GB
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | AMC | 0.25 | 0.26 | +3.4% | 10.44 | +2.9% | +3.1% | +2.9% | -1.8% | -2.4% | -1.3% | — |
| Oct 30, 2025 | AMC | 0.24 | 0.14 | -42.8% | 9.18 | +0.4% | +1.0% | +1.2% | -0.6% | -0.1% | +1.1% | — |
| Aug 7, 2025 | AMC | 0.24 | 0.08 | -67.3% | 9.46 | +0.3% | +0.8% | -0.7% | +1.2% | +1.1% | +0.1% | — |
| Feb 27, 2025 | AMC | 25.25 | 0.05 | -99.8% | 9.79 | +4.2% | +4.0% | +3.9% | +0.9% | -1.2% | -1.4% | — |
| Oct 31, 2024 | AMC | 0.11 | 0.14 | +27.3% | 9.69 | +1.1% | +0.4% | +0.3% | +0.1% | -2.4% | +0.6% | — |
| May 1, 2024 | AMC | 0.11 | 0.12 | +9.1% | 8.35 | -0.8% | -0.4% | -0.2% | -0.7% | +1.1% | -1.7% | — |
| Feb 29, 2024 | AMC | 10.27 | 6.54 | -36.3% | 8.56 | -1.5% | -1.3% | -1.7% | +0.2% | +0.0% | +2.6% | — |
| Aug 2, 2023 | AMC | 0.22 | 0.08 | -63.5% | 8.32 | +0.0% | +0.6% | -1.3% | +1.3% | +0.5% | +0.8% | — |
| Mar 2, 2023 | AMC | 0.23 | 0.21 | -9.7% | 7.63 | +0.8% | +1.8% | +1.0% | -0.9% | +0.1% | -0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 23 | Barclays | Upgrade | Equal Weight → Overweight | — | $10.33 | $10.36 | +0.3% | +1.3% | -0.9% | +0.5% | -1.1% | -0.1% |
| Sep 16 | Barclays | Downgrade | Overweight → Equal Weight | — | $9.68 | $9.35 | -3.4% | -4.1% | +1.3% | -1.7% | -0.9% | -1.7% |
| Sep 20 | Morgan Stanley | Maintains | Overweight → Overweight | — | $10.46 | $10.45 | -0.1% | +0.6% | +1.0% | +0.3% | -0.7% | +0.0% |
| Mar 26 | Argus | Maintains | Buy → Buy | — | $8.43 | $8.41 | -0.2% | -0.2% | +1.4% | -0.5% | -1.8% | -0.7% |
| Apr 6 | Argus | Upgrade | Hold → Buy | — | $8.63 | $8.81 | +2.1% | +3.9% | -1.3% | -0.9% | +0.7% | -0.9% |
| Sep 28 | Argus | Maintains | Hold → Hold | — | $5.85 | $5.86 | +0.2% | +2.2% | +2.2% | -0.3% | +0.8% | +1.6% |
| Jul 29 | Deutsche Bank | Maintains | Hold → Hold | — | $7.00 | $6.92 | -1.1% | +0.4% | +4.8% | +0.4% | -1.4% | +0.1% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Dodge & Cox | 146,539,663 | $1.5B | Reduced | Mar 2026 |
| 2 | Fmr Llc | 113,969,159 | $1.1B | Added | Mar 2026 |
| 3 | Morgan Stanley | 42,990,766 | $435M | Added | Dec 2025 |
| 4 | Clearbridge Investments, Llc | 31,718,725 | $318M | Added | Mar 2026 |
| 5 | Arrowstreet Capital, Limited Partnership | 14,674,518 | $147M | Added | Mar 2026 |
| 6 | Bank Of America Corp /de/ | 10,934,228 | $109M | Added | Mar 2026 |
| 7 | Natixis Advisors, Llc | 9,198,299 | $92M | Reduced | Mar 2026 |
| 8 | Nuveen, Llc | 8,699,093 | $87M | Added | Mar 2026 |
| 9 | Jpmorgan Chase & Co | 8,279,468 | $83M | Added | Mar 2026 |
| 10 | First Eagle Investment Management, Llc | 8,065,286 | $81M | Added | Mar 2026 |
| 11 | Aristotle Capital Management, Llc | 7,825,273 | $79M | Reduced | Dec 2025 |
| 12 | Douglas Lane & Associates, Llc | 6,693,783 | $67M | Reduced | Mar 2026 |
| 13 | Point72 Asset Management | 6,574,038 | $66M | Added | Mar 2026 |
| 14 | Raymond James Financial Inc | 6,264,041 | $63M | Added | Mar 2026 |
| 15 | Rockefeller Capital Management L.p. | 5,103,509 | $51M | Reduced | Mar 2026 |
| 16 | Northern Trust Corp | 4,881,337 | $49M | Added | Mar 2026 |
| 17 | Wells Fargo & Company/mn | 4,022,749 | $40M | New | Mar 2026 |
| 18 | Cibc Bancorp Usa Inc. | 3,953,513 | $40M | New | Mar 2026 |
| 19 | Royal Bank Of Canada | 3,063,916 | $31M | Added | Mar 2026 |
| 20 | Bank Of New York Mellon Corp | 2,596,454 | $26M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$40.99B
Enterprise Value
$48.02B
P/E (TTM)
14.96x
Forward P/E
22.17x
PEG Ratio
1.65x
P/B
2.53x
P/S
2.17x
P/FCF
21.23x
EV/EBITDA
10.10x
Shares Out
4.51B
Financials (TTM)
Revenue
$19.27B
Net Income
$2.78B
EBITDA
$4.76B
Free Cash Flow
$1.97B
Op Cash Flow
$2.29B
EPS Basic
$0.36
EPS Diluted
$0.62
EPS Forward
$0.42
Gross Margin
63.8%
Op Margin
21.3%
Net Margin
14.4%
Balance Sheet
Total Assets
$32.57B
Total Liab.
$16.12B
Total Equity
$16.46B
Cash
$1.32B
LT Debt
$7.76B
Book Value/Sh
$3.67
Debt/Equity
0.52x
Current Ratio
0.92
Quick Ratio
0.71
Returns & Growth
ROE
—
ROA
—
ROIC
6.6%
Rev Growth YoY
-4.0%
EPS Growth YoY
+12.5%
Price Returns
2W
+1.7%
1M
-1.9%
3M
-18.2%
6M
-7.4%
12M
-20.2%
Technicals
52W High
$11.28
52W Low
$8.65
50d MA
$9.20
200d MA
$9.70
RSI (14)
62.20
ATR (14)
$0.14
Beta
0.33
Avg Volume
9.5M
Dividends
Div Rate
$0.13
Div Yield
1.4%
Frequency
2
Ex-Div Date
Apr 10, 2026
Analyst Price Targets
Consensus
$10.20
High
$10.20
Low
$10.20
Median
$10.20
Data updated apr 26, 2026 10:51am
· Source: financialmodelingprep.com